PD-1 and PDL-1 Immune Checkpoint Inhibitors: Emerging Hope for the Future of Lung Cancer Immunotherapy. Faculty of Medicine, Tadulako University, P-ISSN: 2407-8441 and e-ISSN 2502-0749. 2025;11(3):445-454. doi:10.22487/htj.v11i3.1723